Clinical Trials Logo

Clinical Trial Summary

Investigate the prevalence of Toxoplasma gondii and Toxocara canis in Uveitis

- serum antibody to T. gondii and T. canis

- PCR with peripheral blood for T. gondii and T. canis

- PCR with aqueous humor for T. gondii and T. canis

- Clinical manifestation of patient with uveitis


Clinical Trial Description

Consecutive patients with uveitis are enrolled in Nune Eye Hospital.

Serum ELISA

- IgM,IgG antibody to Toxoplasma gondii

- IgG antibody to Toxocara canis

PCR

- PCR with serum and aqueous humor to Toxoplasma gondii

- PCR with serum and aqueous humor to Toxocara canis Clinical characteristics

- visual acuity

- intraocular pressure (IOP)

- location and degree of inflammation

- other fundus findings were recorded

questionnaire

- environment, occupation

- pet ownership, exposure to animal

- history of eating raw liver of animal, raw beef or any other raw flesh of animal. ;


Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01837056
Study type Observational [Patient Registry]
Source National Institute of Health, Korea
Contact
Status Completed
Phase N/A
Start date January 2011
Completion date February 2012

See also
  Status Clinical Trial Phase
Recruiting NCT04101604 - Biomarkers of Common Eye Diseases
Active, not recruiting NCT04704609 - Imaging Quantification of Inflammation (IQI)
Completed NCT03173144 - Chronic Inflammatory Disease, Lifestyle and Treatment Response
Withdrawn NCT01280669 - Intravitreal Sirolimus as Therapeutic Approach to Uveitis Phase 2
Terminated NCT02907814 - Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography N/A
Active, not recruiting NCT02252328 - Use of Simvastatin as a Steroid Sparing Agent for Uveitis Patients Phase 2/Phase 3
Completed NCT04183387 - Simvastatin in Uveitis Phase 2
Completed NCT01983488 - Clinical Outcome in Uveitis
Withdrawn NCT00499551 - A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis Phase 1/Phase 2
Completed NCT00132691 - Multicenter Uveitis Steroid Treatment (MUST) Trial Phase 4
Terminated NCT00114062 - Study to Treat Uveitis Associated Macular Edema Phase 2
Completed NCT00476593 - Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications N/A
Completed NCT00001867 - Effect of Pregnancy on Uveitis N/A
Completed NCT00379275 - Eye and Immunogenetic Features of Sarcoidosis N/A
Active, not recruiting NCT03828019 - Adalimumab vs. Conventional Immunosuppression for Uveitis Trial Phase 3
Terminated NCT01939691 - Macular Edema Nepafenac vs. Difluprednate Uveitis Trial Phase 4
Active, not recruiting NCT03889860 - Objective Choroidal Thickness Measurements in Uveitis
Completed NCT00070759 - Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis Phase 2
Recruiting NCT05486468 - The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment Phase 3
Active, not recruiting NCT05385757 - UNICORNS: Uveitis in Childhood Prospective National Cohort Study